Bank Of America Corp Autolus Therapeutics PLC Transaction History
Bank Of America Corp
- $1.21 Trillion
- Q1 2025
A detailed history of Bank Of America Corp transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Bank Of America Corp holds 32,595 shares of AUTL stock, worth $49,544. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,595
Previous 46,598
30.05%
Holding current value
$49,544
Previous $109,000
54.13%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding AUTL
# of Institutions
100Shares Held
163MCall Options Held
0Put Options Held
88.3K-
Wellington Management Group LLP Boston, MA27.1MShares$41.2 Million0.01% of portfolio
-
Blackstone Inc New York, NY20.5MShares$31.1 Million0.14% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$27.1 Million0.97% of portfolio
-
Syncona Portfolio LTD Guernsey, Channel Islands, X016.6MShares$25.3 Million97.79% of portfolio
-
Armistice Capital, LLC New York, NY11MShares$16.7 Million0.26% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $138M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...